No abstract available.
Fetal Death*

No abstract available.
Fetal Death*

No abstract available.
Fetal Death*

The objective of this investigation was to evaluate dose-incidence relationships on the prenatal effects of gamma-radiation. Pregnant ICR mice were exposed on day 11.5 after conception, coincident with the most sensitive stage for the induction of major congenital malformations, with 0.5-4.0 Gy of gamma-radiations. The animals were sacrificed on day 18 of gestation and the fetuses were examined for mortality, growth retardation, change in head size and any other morphological abnormalities. With increasing radiation dose, incidence of small head, growth retarded fetuses, cleft palate, dilatation of cerebral ventricle and abnormalities of the extremities in live fetuses rose. The threshold doses of radiation that induced cleft palate and dilatation of cerebral ventricle, and abnormal extremities were between 1.0 and 2.0 Gy, and between 0.5 and 1.0 Gy, respectively.
Animals ; Bone and Bones/*abnormalities/radiation effects ; Congenital Abnormalities/embryology/epidemiology/*radionuclide imaging ; Female ; Fetal Death ; Fetal Resorption/epidemiology/radionuclide imaging ; *Gamma Rays ; Incidence ; Mice ; Mice, Inbred ICR ; Pregnancy ; *Prenatal Exposure Delayed Effects ; *Whole-Body Irradiation

No abstract available.
Chickenpox* ; Fetal Death* ; Pregnancy*

No abstract available.
Constriction, Pathologic* ; Fetal Death*

No abstract available.
Fetal Death* ; Gastroschisis*

No abstract available.
Fetal Death* ; Umbilical Cord*

Objective: To investigate the clinical characteristics and maternal and fetal prognosis of pregnant women with acute fatty liver of pregnancy (AFLP). Methods: The clinical data of 86 AFLP pregnant women admitted to the Third Affiliated Hospital of Guangzhou Medical University from September 2017 to August 2022 were collected, and their general data, clinical characteristics, laboratory tests and maternal and fetal outcomes were retrospectively analyzed. Results: (1) General information: the age of the 86 pregnant women with AFLP was (30.8±5.4) years, and the body mass index was (21.0±2.5) kg/m². There were 50 primiparas (58.1%, 50/86) and 36 multiparas (41.9%, 36/86). There were 64 singleton pregnancies (74.4%, 64/86) and 22 twin pregnancies (25.6%, 22/86). (2) Clinical characteristics: the main complaints of AFLP pregnant women were gastrointestinal symptoms, including epigastric pain (68.6%, 59/86), nausea (47.7%, 41/86), anorexia (46.5%, 40/86), vomiting (39.5%, 34/86). The main non-gastrointestinal symptoms were jaundice of skin and/or scleral (54.7%, 47/86), edema (38.4%, 33/86), fatigue (19.8%, 17/86), bleeding tendency (16.3%, 14/86), polydipsia or polyuria (14.0%, 12/86), skin itching (8.1%, 7/86), and 17.4% (15/86) AFLP pregnant women had no obvious symptoms. (3) Laboratory tests: the incidence of liver and kidney dysfunction and abnormal coagulation function in AFLP pregnant women was high, and the levels of blood ammonia, lactate dehydrogenase and lactic acid were increased, and the levels of hemoglobin, platelet and albumin decreased. However, only 24 cases (27.9%, 24/86) of AFLP pregnant women showed fatty liver by imageology examination. (4) Pregnancy outcomes: ① AFLP pregnant women had a high incidence of pregnancy complications, mainly including renal insufficiency (95.3%, 82/86), preterm birth (46.5%, 40/86), hypertensive disorders in pregnancy (30.2%, 26/86), gestational diabetes mellitus (36.0%, 31/86), fetal distress (24.4%, 21/86), pulmonary infection (23.3%, 20/86), disseminated intravascular coagulation (16.3%, 14/86), multiple organ dysfunction syndrome (16.3%, 14/86), hepatic encephalopathy (9.3%, 8/86), and intrauterine fetal death (2.3%, 2/86). ② Treatment and outcome of AFLP pregnant women: the intensive care unit transfer rate of AFLP pregnant women was 66.3% (57/86). 82 cases were improved and discharged after treatment, 2 cases were transferred to other hospitals for follow-up treatment, and 2 cases (2.3%, 2/86) died. ③ Neonatal outcomes: except for 2 cases of intrauterine death, a total of 106 neonates were delivered, including 39 cases (36.8%, 39/106) of neonatal asphyxia, 63 cases (59.4%, 63/106) of neonatal intensive care unit admission, and 3 cases (2.8%, 3/106) of neonatal death. Conclusions: AFLP is a severe obstetric complication, which is harmful to mother and fetus. In the process of clinical diagnosis and treatment, attention should be paid to the clinical manifestations and laboratory tests of pregnant women, early diagnosis and active treatment, so as to improve maternal and fetal outcomes.
Pregnancy ; Infant, Newborn ; Female ; Humans ; Adult ; Retrospective Studies ; Premature Birth/epidemiology* ; Pregnancy Complications/diagnosis* ; Fatty Liver/diagnosis* ; Fetal Death ; Stillbirth

Pure fetal blood was obtained by cordocentesis or cardiocentesis guided by USG in 160 fetuses at 15 to 37 weeks' gestation. Only 1 case failed to obtain cytogenetic result. Cytogenetic analysis of fetal lymphocytes yielded results within 5 days. Chromosomal abnormalities were found in 21 of 159 fetuses(13.2%). Abnormal karyotypes were found in 19 of 118 fetuses(16.1%) with structural malformations~8.6%(7/81) affected by isolated malformations vs. 32.4%(12/37) affected by multiple malformations. There were 12 cases of bradycardia which was the most common nonfatal complication (7.4%). One fetal death was recorded. Pregnancy outcome is as follows: 17 cases of stillbirth, 38 cases of termination of pregnancy, 15 cases of neonatal death, 5 cases of infantile death, 55 cases of living babies, and 29 cases lost to follow-up. It is concluded that rapid karyotyping by cordocentesis is advisable as effective method in fetuses at high risk of a chromosomal aberration, especially in advanced gestations.
Abnormal Karyotype ; Bradycardia ; Chromosome Aberrations ; Cordocentesis* ; Cytogenetic Analysis* ; Cytogenetics* ; Female ; Fetal Blood ; Fetal Death ; Fetus ; Karyotyping ; Lost to Follow-Up ; Lymphocytes ; Pregnancy ; Pregnancy Outcome ; Stillbirth